Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SanBio Co Ltd (4592 JP)
Watchlist
57
Analysis
Health Care
•
Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
24 Sep 2018 17:36
Japan Fortnightly Update: Celebration
APATHY STRIKES AGAINTHE APATHY INDICATOR - Our Fortnightly Update for 26th August highlighted the lack of market activity after the end of the...
Campbell Gunn
Follow
480 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Aug 2018 16:31
Japan Fortnightly Update: Turning Point
TURNING POINT - Despite the last four trading days being 'up', the Japanese equity market composite fell by 0.6% over the last two weeks. New...
Campbell Gunn
Follow
606 Views
Share
bullish
•
Thematic (Sector/Industry)
•
28 May 2018 18:08
Japan: Scoring Results & Forecasts - Part 3 - Company Winners & Losers
INTRODUCTION - The final part of our Results and Forecast/Revision Scores review will look at the leading and lagging performers and forecasters...
Campbell Gunn
Follow
482 Views
Share
bullish
•
SanBio Co Ltd
•
22 Sep 2025 08:30
SanBio Co Ltd (4592 JP): Akuugo Approval Awaited; Plans Negotiation for Ischemic Stroke Trials
SanBio revised FY26 operating loss guidance to reflect higher manufacturing expenses to secure the inventory necessary for future clinical trials...
Tina Banerjee
Follow
396 Views
Share
bullish
•
SanBio Co Ltd
•
18 Jun 2025 17:21
SanBio Co Ltd (4592 JP): Akuugo Shipments Expected To Commence In 2QFY26, New Credit Line In Place
SanBio reports Q1FY26 result. Higher R&D expenses (¥ 723M) and foreign exchange losses (¥ 711M) led to a net loss of ¥ 1,531M (vs ¥ 144M in...
Tina Banerjee
Follow
1.1k Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x